What's new

Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Date of authorisation: 26/07/2018, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Date of authorisation: 26/07/2018, Revision: 17, Status: Authorised

Apr 29, 2025 - 13:51
 0
Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Date of authorisation: 26/07/2018, Revision: 17, Status: Authorised
Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Date of authorisation: 26/07/2018, Revision: 17, Status: Authorised
Read More

Tags:

Previous Article

DHL drops embargo on medium-value goods after US walks back customs rule

Next Article

Ferrari 296 Speciale revealed with 868bhp and radical aero set-up

Related Posts

Report - Industry stakeholders and EU network experts s...

Apr 26, 2025  0

Summary of opinion: Adcetris, 25/04/2025 Positive

Summary of opinion: Adcetris, 25/04/2025 Positive

Apr 25, 2025  0

European Medicines Agency’s data protection notice for ...

Apr 22, 2025  0